Earnings Preview: KPTI to Report Financial Results Pre-market on February 19

Moomoo NewsFeb 13 06:45 ET

Karyopharm to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025

Karyopharm TherapeuticsFeb 12 00:00 ET

RBC Capital Maintains Karyopharm Therapeutics(KPTI.US) With Buy Rating, Maintains Target Price $3

Moomoo NewsFeb 10 07:33 ET · Ratings

Express News | Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

ReutersFeb 3 16:05 ET

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Karyopharm TherapeuticsFeb 3 00:00 ET

Express News | HC Wainwright & Co. Reiterates Buy on Karyopharm Therapeutics, Maintains $7 Price Target

BenzingaJan 15 06:53 ET